Published in Exp Cell Res on February 25, 1998
Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med (2003) 2.23
Alterations in marginal zone macrophages and marginal zone B cells in old mice. J Immunol (2011) 1.09
A microarray screen for novel candidate genes in coeliac disease pathogenesis. Gut (2004) 1.02
Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond. BMC Immunol (2012) 1.01
Editing antigen presentation: antigen transfer between human B lymphocytes and macrophages mediated by class A scavenger receptors. J Immunol (2008) 0.95
Contributions of B cells to lupus pathogenesis. Mol Immunol (2013) 0.87
Inhibition of antigen trafficking through scavenger receptor A. J Biol Chem (2012) 0.87
Transfer of antigen from human B cells to dendritic cells. Mol Immunol (2013) 0.77
Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis (1986) 5.23
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1995) 3.54
Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis (1999) 3.21
Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation (2000) 3.17
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest (1991) 2.76
Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Proc Natl Acad Sci U S A (1984) 2.40
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proc Natl Acad Sci U S A (1986) 2.34
Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest (1998) 2.27
Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest (1985) 2.16
T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb (1992) 2.09
gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor. Proc Natl Acad Sci U S A (1985) 2.07
Epstein-Barr virus susceptibility of normal human B lymphocyte populations. J Exp Med (1984) 1.94
Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol (1996) 1.88
Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest (1992) 1.83
Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest (1998) 1.80
Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an IgH/myc translocation-carrying BL line. Int J Cancer (1989) 1.74
Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol (1986) 1.70
In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation (2001) 1.69
Nuclear factor kappa-B and the heart. J Am Coll Cardiol (2001) 1.68
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation (2001) 1.63
Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res (1992) 1.56
Correlations between clinical variables and gene-expression profiles in carotid plaque instability. Eur J Vasc Endovasc Surg (2011) 1.50
Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet (1988) 1.46
Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol (1996) 1.41
Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype. Am J Pathol (1991) 1.39
LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol (2001) 1.39
Reduced frequency of memory CD8+ T lymphocytes in cerebrospinal fluid and blood of patients with multiple sclerosis. Autoimmunity (1995) 1.39
Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci U S A (1988) 1.38
Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA. Int J Cancer (1985) 1.38
Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc Natl Acad Sci U S A (1986) 1.38
Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis (1999) 1.38
Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest (1991) 1.35
The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J Immunol (1989) 1.32
Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2000) 1.30
Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. J Gen Virol (1991) 1.30
A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother (1985) 1.29
Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line. J Gen Virol (1998) 1.28
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A (1999) 1.28
Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes. Mol Med (1995) 1.26
Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Lab Invest (1989) 1.21
Activation of inducible nitric oxide synthase/nitric oxide by curli fibers leads to a fall in blood pressure during systemic Escherichia coli infection in mice. J Infect Dis (2001) 1.19
Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen. Scand J Immunol (2004) 1.19
Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages. Biochim Biophys Acta (1990) 1.18
Smooth muscle cells express Ia antigens during arterial response to injury. Lab Invest (1988) 1.18
Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand J Immunol (1999) 1.17
Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res (1991) 1.14
Fc-mediated binding of IgG to vimentin-type intermediate filaments in vascular endothelial cells. Proc Natl Acad Sci U S A (1984) 1.14
Capacity of B-lymphocytic lines of diverse tumor origin to produce and respond to B-cell growth factors: a progression model for B-cell lymphomagenesis. Int J Cancer (1985) 1.14
Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis (1990) 1.13
Immunohistochemical localization of lipoprotein lipase in human adipose tissue. Atherosclerosis (1984) 1.12
Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med (2008) 1.12
Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall. Thromb Haemost (2011) 1.10
Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen. Int J Cancer (1986) 1.10
Evidence for antigen-driven T-cell response in unstable angina. Circulation (2000) 1.09
Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08
Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb (1994) 1.07
Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions. Acta Pathol Microbiol Immunol Scand A (1984) 1.07
Immune mechanisms in atherosclerosis. Coron Artery Dis (1994) 1.06
Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res (1998) 1.06
Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res (1996) 1.04
Human arterial smooth muscle cells in culture: inverse relationship between proliferation and expression of contractile proteins. In Vitro Cell Dev Biol (1989) 1.04
Ultrastructural studies on the localization of IgG in the aortic endothelium and subendothelial intima of atherosclerotic and nonatherosclerotic rabbits. Exp Mol Pathol (1980) 1.02
Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res (1999) 1.01
The macrophage scavenger receptor type A directs modified proteins to antigen presentation. Eur J Immunol (1999) 1.01
Expression of interleukin-15 in mouse and human atherosclerotic lesions. Am J Pathol (2001) 1.00
Evidence for cell death in the vascular endothelium in vivo and in vitro. Am J Pathol (1983) 1.00
Aortic endothelial cell death and replication in normal and lipopolysaccharide-treated rats. Am J Pathol (1985) 1.00
Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. Exp Cell Res (1988) 0.99
Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol (1993) 0.98
Fc-dependent binding of monocytes to areas with endothelial injury in the rabbit aorta. Exp Mol Pathol (1981) 0.96
Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation. Arterioscler Thromb Vasc Biol (1999) 0.96
Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions. J Clin Invest (1989) 0.96
Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler Thromb Vasc Biol (1995) 0.96
The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol (2005) 0.95
Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARalpha-dependent signaling pathway. Arterioscler Thromb Vasc Biol (1999) 0.95
MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin. Immunology (1990) 0.95
Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg (2000) 0.95
Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection. J Virol (1990) 0.95
Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages. J Lipid Res (1987) 0.94
Isolation and characterization of endothelial cells from the epididymal fat pad of the rat. J Lipid Res (1983) 0.93
Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations. J Immunol (1985) 0.93
The Epstein-Barr virus determined nuclear antigen is composed of at least three different antigens. Int J Cancer (1986) 0.92
Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp Cell Res (1994) 0.92
Expression of B-cell-specific markers in different Burkitt lymphoma subgroups. Int J Cancer (1987) 0.92
Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFkappaB and AP-1. Cardiovasc Res (2000) 0.91
Genetic variants of TNFSF4 and risk for carotid artery disease and stroke. J Mol Med (Berl) (2008) 0.91
Immunological mechanisms in atherosclerosis. J Intern Med (1995) 0.90
CD4+ and CD8+ T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis. Arthritis Rheum (1994) 0.90
Induction of nitric oxide synthase in a model of allergic occupational asthma. Allergy (1995) 0.89
cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells. Biochim Biophys Acta (1994) 0.89
Cyclosporine A inhibits induction of DNA synthesis by PDGF and other peptide mitogens in cultured rat aortic smooth muscle cells and dermal fibroblasts. Growth Factors (1991) 0.89
Distinction between Burkitt lymphoma subgroups by monoclonal antibodies: relationships between antigen expression and type of chromosomal translocation. Int J Cancer (1984) 0.89
Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts. Am J Pathol (1996) 0.89
Plasma protein accumulation in injured endothelial cells. Immunofluorescent localization of IgG and fibrinogen in the rabbit aortic endothelium. Exp Mol Pathol (1979) 0.89
Induction of CD36 by all-trans retinoic acid: retinoic acid receptor signaling in the pathogenesis of atherosclerosis. FASEB J (2001) 0.89
IgG binding to cytoskeletal intermediate filaments activates the complement cascade. Exp Cell Res (1987) 0.88
The contribution of inducible nitric oxide and cytomegalovirus to the stability of complex carotid plaque. J Vasc Surg (1999) 0.88
Differential regulation of macrophage scavenger receptor isoforms: mRNA quantification using the polymerase chain reaction. J Lipid Res (1995) 0.87
EGNA-specific LIF production of human lymphocyte subsets. Cell Immunol (1984) 0.87